Healthcare Triangle, Inc. (HCTI) — Financial statements
Income statement, balance sheet, and cash flow for Healthcare Triangle, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 14↑18.8% | 12↓64.8% | 33↓27.6% | 46↑30.1% | 35 | |
| Cost of Revenue | 12↑36.3% | 9↓66.7% | 26↓23.6% | 35↑39.8% | 25 | |
| Gross Profit | 2↓34.6% | 3↓57.4% | 7↓40.0% | 11↑7.3% | 11 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.54↑24.9% | 0.43↓46.3% | 0.80↓90.2% | 8↑54.8% | 5 | |
| General & Administrative Expenses | 7↑85.7% | 4↓31.0% | 6↑3.7% | 6↑24.4% | 4 | |
| Selling & Marketing Expenses | 3↑40.0% | 2↓52.8% | 5↓29.8% | 7↑39.7% | 5 | |
| SG&A Expenses | 10↑69.4% | 6↓40.8% | 10↓14.6% | 12↑32.3% | 9 | |
| Other Expenses | 0.72↓31.8% | 1↓67.7% | 3↓55.2% | 7↑413.9% | 1 | |
| Operating Expenses | 12↑52.8% | 8↓47.2% | 14↓47.6% | 28↑73.9% | 16 | |
| Total Costs & Expenses | 24↑44.0% | 16↓59.8% | 41↓34.3% | 62↑53.1% | 41 | |
| Operating Results | ||||||
| Operating Income | -10↓106.0% | -5↑38.3% | -8↑52.9% | -16↓204.6% | -5 | |
| Depreciation & Amortization | 0.71↓20.7% | 0.89↓43.2% | 2↓46.8% | 3↑106.9% | 1 | |
| EBITDA | -9↓135.6% | -4↑37.0% | -6↑42.8% | -11↓171.8% | -4 | |
| EBIT | -10↓106.3% | -5↑38.3% | -8↑43.7% | -14↓154.6% | -5 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.57↑53.3% | -1↓25.3% | -0.97↓356.6% | -0.21↑62.6% | -0.57 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.57↓53.3% | 1↑25.3% | 0.97↑356.6% | 0.21↓62.6% | 0.57 | |
| Non-Operating Income | 0.00↑100.0% | -0.01↑41.7% | -0.01↑99.6% | -3 | 0.00 | |
| Other Income / Expenses | 0.31↑126.0% | -1↓26.2% | -0.96↓138.7% | 2↑535.8% | -0.57 | |
| Income Before Tax | -9↓59.1% | -6↑31.1% | -9↑37.5% | -14↓133.8% | -6 | |
| Income Tax Expense | 0.00↓100.0% | 0.01↓65.7% | 0.04↓93.1% | 0.51↑2008.3% | 0.02 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -9↓58.8% | -6↑31.3% | -9↑39.5% | -14↓141.4% | -6 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -9↓58.8% | -6↑31.3% | -9↑39.5% | -14↓141.4% | -6 | |
| Bottom-Line Net Income | -9↓58.8% | -6↑31.3% | -9↑39.5% | -14↓141.4% | -6 | |
| EPS (Basic) | -153.15↑99.1% | -16,895.00↑45.6% | -31,051.00↑46.5% | -57,998.00↓92.0% | -30,207.00 | |
| EPS (Diluted) | -153.15↑99.1% | -16,895.00↑45.6% | -31,051.00↑46.5% | -57,998.00↓92.0% | -30,207.00 | |
| Weighted Average Shares | 0.06↑17427.8% | 0.00↑26.5% | 0.00↑13.0% | 0.00↑26.0% | 0.00 | |
| Weighted Average Diluted Shares | 0.06↑17427.8% | 0.00↑26.5% | 0.00↑13.0% | 0.00↑26.0% | 0.00 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.